Role of vitamin D in calcium homeostasis and its use in prevention of bovine periparturient paresis

Acta Veterinaria Scandinavica, Supplement

Volumn , Issue 97, 2004, Pages 35-50

  Horst, R L ^a   Goff, J P ^a   Reinhardt, T A ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

Dairy cows; Milk fever prevention; Periparturient paresis; Vitamin D

Indexed keywords

ALFACALCIDOL; CALCIFEDIOL; CALCITRIOL; CALCITRIOL DERIVATIVE; CALCIUM; COLECALCIFEROL; DRUG METABOLITE; ERGOCALCIFEROL; VITAMIN D DERIVATIVE;

ASSOCIATION; CALCIUM HOMEOSTASIS; CATTLE DISEASE; CONFERENCE PAPER; DAIRY CATTLE; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; DRUG USE; HYPOCALCEMIA; NONHUMAN; PARTURIENT PARESIS; PROPHYLAXIS;

ANIMALIA; AVES; BOS TAURUS; BOVINAE; MAMMALIA;

EID: 1842638132     PISSN: 00651699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (102)

1. Bar A, Hurwitz S, Sachs M: Further observations on the use of 1a-hydroxycholecalciferol in the prevention of bovine parturient paresis. Bovine Practitioner. 1980, 15, 67-71.
2. 3, calcium, and hydroxyproline. J. Dairy Sci. 1985, 68, 1952-1958.
3. Barlet J-P, Davicco M-J: 1a-hydroxycholecalciferol for the treatment of the downer cow. J. Dairy Sci. 1992, 75, 1253-1256.
4. 3 administration increases the incidence of milk fever. J. Dairy Sci. 1984, 67, 1236-1239.
5. Beede DK: Dietary cation-anion difference: Preventing milk fever. Feed Management. 1992, 43, 28-31.
6. Bikle DD, Gee E, Halloran B, Haddad JG: Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J. Clin. Invest. 1984, 74, 1966-1971.
7. Bikle DD, Siiteri PK, Ryzen E, Haddad JG, Gee E: Serum protein binding of 1,25-dihydroxyvitamin D: A reevaluation by direct measurement of free metabolite levels. J. Clin. Endocr. Metab. 1985, 61, 969-975.
8. 3. Biochem. 1968, 7, 3317-3322.
9. 3 metabolites. Nutr. Rev. 1986, 44, 1-8.
10. Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A: Vitamin D metabolism and bone mineralization in man. J. Clin. Endocr. Metab. 1978, 46, 284-294.
11. Broadus AE, Horst RL, Lang RL, Littledike ET, Rasmussen H: The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism. New Engl. J. Med. 1980, 302, 421-426.
12. Canas FM, Ortiz OE, Asteggiano CA, Pereira RD: Effects of Solanum malacoxylon extract on rachitic chicks. Comparative study with vitamin D3. Calcif Tissue Res 1977, 23, 297-301.
13. Canterbury JM, Lerman S, Claflin AJ, Henry H, Norman A, Reiss E: Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog. J. Clin. Invest. 1977, 78, 1375-1383.
14. Capen CC, Cole CR, Hibbs JW: The pathology of hypervitaminosis D in cattle. Pathol. Vet. 1966, 3, 350-378.
15. 3 regulation. Calcif. Tis. Res. 1977, 22 (Suppl.), 29-34.
16. Counts SJ, Baylink DJ, Shen FH, Sherrard DJ, Hickman RO: Vitamin D intoxication in an anephric child. Ann. Int. Med. 1975, 82, 196-200.
17. 3) in the prevention of milk fever. Vet. Rec. 1978, 102, 440-442.
18. de Boland AR, Esparza M, Gallego S, Skliar ML, Boland RL: Modification by rumen of vitamin D-like activity of Solanum malacoxylon in rats. Acta Physiol. Lat. Am. 1979, 29, 285-290.
19. DeLuca HF: New concepts of vitamin D functions. Ann. N.Y. Acad. Sci. 1992, 669, 59-69.
20. Dirksen G, Fricke R: Prophylaxis of parturient paresis in dairy cows by oral application of Solanum malacoxylon., Sixth Intern.Conf. Prod. Dis. Farm Anim. Dublin, Ireland, 1986, p. 28-31.
21. Esparza MS, Vega M, Boland RL: Synthesis and composition of vitamin D-3 metabolites in Solanum malacoxylon. Biochim. Biophys. Acta 1982, 719, 633-640.
22. Frank FR, Olgivie ML, Koshy KT, Kakuk TJ, Jorgensen NA: Parturient paresis prophylaxis with 25-hydroxycholecalciferol. Walter de Gruyter, Berlin, Vitamin D:Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism Asilomar, California, 1977, p. 577.
23. 3 for prevention of parturient paresis. J. Dairy Sci. 1979, 62, 1009-1013.
24. 3 for prevention of parturient paresis. J. Dairy Sci. 1977, 60, 1910-1920.
25. 3 on incidence of parturient paresis in dairy cows. J. Dairy Sci. 1990, 73, 406-412.
26. Goff JP, Horst RL: Use of hydrochloric acid as a source of anions for prevention of milk fever. J. Dairy Sci. 1998, 81, 2874-2880.
27. 3 to prevent parturient paresis in dairy cows. J. Dairy Sci. 1988, 71, 1211-1219.
28. Goff JP, Horst RL, Mueller FJ, Miller JK, Kiess GA, Dowlen HH: Addition of chloride to a prepartal diet high in cations increases 1,25-dihydroxyvitamin D response to hypocalcemia preventing milk fever. J. Dairy Sci. 1991, 74, 3863-3871.
29. 3 in pregnancy. Sci. 1979, 204, 1311-1312.
30. Green HB, Horst RL, Beitz DC, Littledike ET: Vitamin D metabolites in plasma of cows fed a prepartum low-calcium diet for prevention of parturient hypocalcemia. J. Dairy Sci. 1981, 64, 217-226.
31. Halloran BP, Barthell EN, DeLuca HF: Vitamin D metabolism during pregnancy and lactation in the rat. Proc. Nat. Acad. Sci. U.S.A. 1979, 76, 5549-5553.
32. 3 in normal subjects. Acta Endocrin. 1987, 115, 378-384.
33. Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK: New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone 1995, 17, 33S-38S.
34. Henry HL, Norman AW: Vitamin D: Two dihydroxylated metabolites are required for normal chicken egg hatchability. Sci. 1978, 201, 835-837.
35. Hibbs JW, Pounden WD: Studies on milk fever in dairy cows. IV. Prevention by short-time, prepartum feeding of massive doses of vitamin D. J. Dairy Sci. 1955, 38, 65-72.
36. 3 reduces parturient paresis in dairy cows fed high dietary calcium. J. Dairy Sci. 1992, 75, 485-491.
37. Hoffsis GF, Capen C, Placke ME, Norman AW: The use of 1,25-dihydroxycholecalciferol in the prevention of parturient hypocalcemia in dairy cows. Bov. Pract. 1979, 13, 88-95.
38. Holick MF, Schnoes HK, DeLuca HF, Suda T, Cousins RJ: Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochem. 1971, 10, 2799-2804.
39. 3 in maternal plasma at delivery. Nutr. Res. 1984, 4, 27-32.
40. Horiuchi N, Caulfield MP, Fisher JE, Goldman ME, McKee RL, Reagan JE, Levy JJ, Nutt RF, Schofield TL, Clemens TL, Rosenblatt M: Similarity of synthetic peptide from human tumor to PTH in vivo and in vitro. Sci. 1988, 238, 1566-1568.
41. Horst RL, Eisman JA, Jorgensen NA, DeLuca HF: Adequate response of plasma 1,25-dihydroxyvitamin D to parturition in paretic (milk fever) dairy cows. Sci. 1977, 196, 662-663.
42. 3 to prevent hypocalcemia in dairy cows. J. Dairy Sci. 2001, 84 (Suppl. 1), 153.
43. Horst RL, Goff JP, Reinhardt TA: Calcium and vitamin D metabolism in the dairy cow. J. Dairy Sci. 1994, 77, 1936-1951.
44. Horst RL, Goff JP, Reinhardt TA: Calcium and vitamin D metabolism during lactation. J. Mammary Gland Biol. Neopl. 1997, 2, 253-263.
45. Horst RL, Littledike ET, Riley JL, Napoli JL: Quantitation of vitamin D and its metabolites and their plasma concentrations in five species of animals. Anal. Biochem. 1981, 116, 189-203.
46. Horst RL, Reinhardt TA: Vitamin D metabolism in ruminants and its relevance to the periparturient cow. J. Dairy Sci. 1983, 66, 661-678.
47. Horst RL, Reinhardt TA: Vitamin D metabolism. 1997, In D. Feldman, F. Gloriex, & J.W. Pike, eds. Vitamin D Academic Press, San Diego, CA.
48. Horst RL, Shepard RM, Jorgensen NA, DeLuca HF: The determination of the vitamin D metabolites on a single plasma sample: Changes during parturition in dairy cows. Archiv. Biochem. Biophys. 1979, 192, 512-523.
49. 3. J. Dairy Sci. 1982, 65, 1934-1940.
50. 3 in prevention of milk fever. Acta Vet. Scand. 1984, 25, 510-525.
51. 3: Application to hypervitaminosis D. J. Clin. Invest. 1976, 58, 61-70.
52. 2. Biochem. 1975, 14, 1250-1256.
53. Jorgensen NA, Horst RL, DeLuca HF, Ogilvie M: 25-Hydroxycholecalciferol for prevention of "milk fever" in dairy cows. Vet. Rec. 1978, 103, 136-138.
54. 3 are differentially modified by 9-cis-retinoic acid. Cancer Res. 1996, 56, 623-632.
55. 3. Biochemical and Biophysical Res. Com. 1994, 202, 1204-1208.
56. Kumar R, Cohen WR, Silva P, Epstein FH: Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. J. Clin. Invest. 1979, 63, 342-344.
57. Kunz W, Hänichen T: Solanum malacoxylon: Investigations on the systemic tolerance of doses recommended for prophylaxis of parturient paresis. Institute fur Physiologie, Tierärztliche Fakultat, Universitat D-8000 Munchen, German Federal Republic, Fourth International Conference on Production Diseases in Farm Animals Munchen, Germany, 1980, p. 211-214.
58. Lawson DEM, Fraser DR, Kodicek E, Morris HR, Williams DH: Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature 1971, 230, 228-230.
59. 3. J. Dairy Sci. 1986, 69, 990-997.
60. Littledike ET, Horst RL: Problems with vitamin D injections for prevention of milk fever: Toxicity of large doses and increased incidence of small doses. J. Dairy Sci. 1979, 63 (Suppl. 1), 89.
61. Littledike ET, Horst RL: Problems with vitamin D injections for prevention of milk fever: Toxicity of large doses and increased incidence of small doses. J. Dairy Sci. 1980, 63, 89.
62. 3 prepartum. Walter de Gruyter, Vitamin D, chemical, biochemical and clinical endocrinology 1982a, p. 475-477.
63. 3 toxicity in dairy cows. J. Dairy Sci. 1982b, 65, 749-759.
64. Lobaugh B, Garner SC, Lovdal JA, Boass A, Toverud SU: Parathyroidectomy abolishes the increase of renal 25-hydroxyvitamin D-1a-hydroxylase in lactating rats. Am. J. Physiol. 1993, 264, E981-E985.
65. Manston R, Mallinson CB, Vagg MJ, Sansom BF: Study of combined injections of 1a-hydroxycholecalciferol and cloprostenol in the prevention of parturient paresis. Vet. Rec. 1981, 109, 357-358.
66. 3 on prevention of parturient paresis. J. Dairy Sci. 1974, 57, 606A.
67. McMurray CH, Rice DA, Gordon F, Humphries D: The potential use of Solanum malacoxylon in the prevention of parturient paresis in dairy cows., Fifth International Conference of Production Disease in Farm Animals Uppsala, Sweden, 1983, p. 22-25.
68. 3 in conjunction with induced parturition. Vet. Rec. 1980, 107, 188-190.
69. Morii H, Lund J, Neville PF, DeLuca HF: Biological activity of a vitamin D metabolite. Archiv. Biochem. Biophys. 1967, 120, 508-512.
70. Napoli JL, Reeve LE, Eisman JA, Schnoes HK, DeLuca HF: Solanum glaucophyllum as source of 1,25-dihydroxyvitamin D3. J. Biol. Chem. 1977, 252, 2580-2583.
71. 3 in the intestine. Sci. 1971, 173, 51-54.
72. O'Donnel JM, Smith MW: Vitamin D-like action of Solanum malacoxylon on calcium transport in rat intestine. Nature 1973, 244, 357-358.
73. Oetzel GR: Use of anionic salts for prevention of milk fever in dairy cattle. The Compendium: Food Animal 1993, 15, 1138-1147.
74. 3). I. Treatment for parturient paresis. J. Dairy Sci. 1973, 56, 885-888.
75. 3). III. Effect of dosage on soft tissue integrity and vitamin D activity of tissue and milk from dairy cows. J. Dairy Sci. 1974, 57, 677-682.
76. Ornoy A, Goodwin D, Noff D, Edelstein S: 24,25-Dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation. Nature. 1978, 276, 517-519.
77. 3 in the prevention of milk fever. Vet. Rec. 1967, 81, 214-216.
78. Peterlik M, Wasserman RH: Stimulatory effect of 1,25- dihydroxycholecalciferol-like substances from Solanum malacoxylon and Cestrum diurnum on phosphate transport in chick jejunum. J. Nutr. 1978, 108, 1673-1679.
79. Puche RC, Bingley JB: Calcinosis of cattle in Argentina. 1995, U.N.R. Editora, Uniververidad Nacional De Rosario, Rupublic Argentina.
80. Ramberg CF Jr, Johnson EK, Fargo RD, Kronfeld DS: Calcium homeostasis in cows, with special reference to parturient hypocalcemia. Am. J. Physiol. 1984, 246, R698-R704.
81. Reinhardt TA, Conrad HR: Mode of action of pharmacological doses of cholecalciferol during parturient hypocalcemia in dairy cows. J. Nutr. 1980, 110, 1589-1594.
82. Reinhardt TA, Horst RL, Orf JW, Hollis BW: A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: Application to clinical studies. J. Clin. Endocrin. Metab. 1984, 55, 91-98.
83. 3 alters retinoic acid metabolism in vivo. Archiv. Biochem. Biophys. 1999, 368, 244-248.
84. Robinson CJ, Spanos E, James MF, Pike JW, Haussler MR, Makeen AM, Hillyard CJ, MacIntyre I: Role of prolactin in vitamin D metabolism and calcium absorption during lactation in the rat. J. Endocrin. 1982, 94, 443-453.
85. Rosol TJ, Capen CC, Horst RL: Effects of infusion of human parathyroid hormone-related protein-(1-40) in nude mice: Histomorphometric and biochemical investigations. J. Bone Min. Res. 1988, 3, 699-706.
86. Roux R, Davicco MJ, Carillo BJ, Barlet JP: Solanum glaucophyllum in pregnant cow. Effect on colostrum mineral composition and plasma calcium and phosphorus levels in dams and newborn calves. Ann. Biol. anim. Bioch. Biophys. 1979, 19, 91-101.
87. Sachs M, Bar A, Cohen R, Mazur Y, Mayer E, Hurwitz S: Use of 1a-hydroxycholecalciferol in the prevention of bovine parturient paresis. Am. J. Vet. Res. 1977, 38, 2039-2041.
88. Sachs M, Nir S, Machnai B, Ochovsky D, Miller Y, Sabag D, Danieli Y, Meir E, Bar A, Hurwitz S, Sterling J, Weiner BZ, Kain N, Seife M, Mazor Z: The use of 1a-hydroxycholecalciferol in the prevention of bovine parturient paresis (milk fever). 1983, Proc. 5th International Conference on Production Disease in Farm Animals, Uppsala, Sweden. pp. 14-18.
89. Sansom BF, Allen WM, Davies DC, Hoare MN, Stenton JR, Vagg MJ: Use of 1a-OH cholecalciferol in preventing post parturient hypocalcaemia and its potential value for the prevention of milk fever in dairy cows. Vet. Rec. 1976a, 99, 310-312.
90. Sansom BF, Vagg MJ, Allen WM: The effects of 1a-hydroxycholecalciferol on the calcium and phosphorus metabolism of dairy heifers. Proceedings of the Nutrition Society 1976b, 35, 55A-56A.
91. 3 intakes. Archiv. Biochem. Biophys. 1980, 202, 43-53.
92. Smith PN, Padilla M, Wasserman RH, Kallfelz FA: Calcium and 24,25-dihydroxyvitamin D: Inverse relation in cows with parturient paresis. Calcif. Tis. Intern. 1982, 34, 564-566.
93. Spanos E, Brown DJ, Stevenson JC, MacIntyre I: Stimulation of 1,25-dihydroxycholecalciferol production by prolactin and related peptides in intact renal cell preparations in vitro. Biochim. Biophys. Acta 1981, 672, 7-15.
94. 3 in lactation. J. Ster. Biochem. 1983, 19, 505-510.
95. Uribe A, Holick MF, Jorgensen NA, DeLuca HF: Action of Solanum malacoxylon on calcium metabolism in the rat. Biochem. Biophys. Res. Comm. 1974, 58, 257-262.
96. Vagg MJ, Allen WM, Davies DC, Sansom BF: Field trial to determine the efficacy of two doses of 1a-hydroxycholecalciferol in the prevention of milk fever. Vet. Rec. 1981, 109, 273-275.
97. Vagg MJ, Payne JM: The effect of ammonium chloride induced acidosis on calcium metabolism in ruminants. Br. Vet. J. 1970, 126, 531-536.
98. 3-glycoside. Science 1976, 194, 853-855.
99. Weissenberg M, Maoz A, Levy A, Wasserman RH: Radioimmunoassay for Rapid Estimation of Vitamin D Derivatives in Calcinogeneic Plants. Plant Medica. 1988, 54, 63-65.
100. Wittwer F, Ford EJH: 1a-Hydroxycholecalciferol in the prevention of milk fever. Vet. Rec. 1978, 102, 442-443.
101. Wittwer F, Ford EJH: The effect of 1a-hydroxycholecalciferol on the concentrations of calcium, magnesium and inorganic phosphate in the plasma of parturient cows. J. Dairy Res. 1980, 47, 177-183.
102. Worker NA, Corrillo: Enteque Seco, calcification and wasting in the Argentine. Nature 1967, 215, 72-73.